These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32088019)

  • 21. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
    Robbins HA; Li Y; Porras C; Pawlita M; Ghosh A; Rodriguez AC; Schiffman M; Wacholder S; Kemp TJ; Gonzalez P; Schiller J; Lowy D; Esser M; Matys K; Quint W; van Doorn LJ; Herrero R; Pinto LA; Hildesheim A; Waterboer T; Safaeian M
    BMC Infect Dis; 2014 Mar; 14():120. PubMed ID: 24588945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating seroprevalence of human papillomavirus type 16 using a mixture model with smoothed age-dependent mixing proportions.
    Vink MA; van de Kassteele J; Wallinga J; Teunis PF; Bogaards JA
    Epidemiology; 2015 Jan; 26(1):8-16. PubMed ID: 25380503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of seropositivity to human papillomavirus type 53: one of the most prevalent high risk-related cervical human papillomaviruses.
    Malik ZA; Hailpern SM; Burk RD
    Viral Immunol; 2008 Sep; 21(3):371-7. PubMed ID: 18681800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.
    Rahman S; Pierce Campbell CM; Rollison DE; Wang W; Waterboer T; Michel A; Pawlita M; Villa LL; Lazcano Ponce E; Borenstein AR; Giuliano AR
    PLoS One; 2016; 11(11):e0167173. PubMed ID: 27902759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
    Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
    Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
    BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5 years of follow-up.
    Huang T; Liu Y; Li Y; Liao Y; Shou Q; Zheng M; Liao X; Li R
    Vaccine; 2018 Mar; 36(11):1368-1374. PubMed ID: 29428178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
    Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
    J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-specific seroprevalence of human papillomavirus 16, 18, 31, and 58 in women of a rural town of Colombia.
    Bedoya AM; Gaviria AM; Baena A; Borrero M; Duarte DF; Combita AL; Castaño J; Grisales H; Sánchez GI
    Int J Gynecol Cancer; 2012 Feb; 22(2):303-10. PubMed ID: 22228426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran.
    Aghakhani A; Mamishi S; Sabeti S; Bidari-Zerehpoosh F; Banifazl M; Bavand A; Ramezani A
    Med Microbiol Immunol; 2017 Apr; 206(2):105-110. PubMed ID: 27858157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
    Vink MA; Berkhof J; van de Kassteele J; van Boven M; Bogaards JA
    PLoS One; 2016; 11(8):e0161109. PubMed ID: 27537200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of Human Papillomavirus (HPV) Type 6, 11, 16, 18, by Anatomic Site of HPV Infection, in Women Aged 16-64 Years living in the Metropolitan Area of San Juan, Puerto Rico.
    Pérez-Caraballo AM; Suarez E; Unger ER; Palefsky JM; Panicker G; Ortiz AP
    P R Health Sci J; 2018 Mar; 37(1):26-31. PubMed ID: 29547681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Human Papillomavirus Seropositivity in Appalachian Women Aged 18 to 26 Years.
    Ruffin MT; Hade EM; Fahey P; Christian LM; Paskett ED; Harper DM
    Sex Transm Dis; 2021 Sep; 48(9):693-699. PubMed ID: 34106566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus-specific antibody status among unvaccinated subjects in the region of Vojvodina, Serbia.
    Kovačević G; Božić Nedeljković B; Patić A; Radovanov J; Hrnjaković-Cvjetković I
    Cent Eur J Public Health; 2023 Mar; 31(1):57-62. PubMed ID: 37086422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
    Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
    J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-Level Herd Protection of Males From a Female Human Papillomavirus Vaccination Program: Evidence from Australian Serosurveillance.
    Pillsbury AJ; Quinn HE; Evans TD; McIntyre PB; Brotherton JML
    Clin Infect Dis; 2017 Sep; 65(5):827-832. PubMed ID: 29017279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
    Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
    J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
    Kreimer AR; Alberg AJ; Viscidi R; Gillison ML
    Sex Transm Dis; 2004 Apr; 31(4):247-56. PubMed ID: 15028941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV).
    Gray P; Luostarinen T; Vänskä S; Eriksson T; Lagheden C; Man I; Palmroth J; Pimenoff VN; Söderlund-Strand A; Dillner J; Lehtinen M
    Int J Cancer; 2019 Aug; 145(3):785-796. PubMed ID: 30719706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of human papillomavirus 6, 11, 16, and 18 in young primiparous women in Sao Paulo, Brazil.
    Rama CH; Villa LL; Pagliusi S; Andreoli MA; Costa MC; Thomann P; Longatto-Filho A; Eluf-Neto J
    Int J Gynecol Cancer; 2010 Nov; 20(8):1405-10. PubMed ID: 21051985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.